Baras, A. S., Drake, C., Liu, J., Gandhi, N., Kates, M., Hoque, M. O., . . . Bivalacqua, T. J. (2016). The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder. Oncoimmunology.

Baras, Alexander S., et al. "The Ratio of CD8 to Treg Tumor-infiltrating Lymphocytes Is Associated With Response to Cisplatin-based Neoadjuvant Chemotherapy in Patients With Muscle Invasive Urothelial Carcinoma of the Bladder." Oncoimmunology 2016.

Baras, Alexander S., et al. "The Ratio of CD8 to Treg Tumor-infiltrating Lymphocytes Is Associated With Response to Cisplatin-based Neoadjuvant Chemotherapy in Patients With Muscle Invasive Urothelial Carcinoma of the Bladder." Oncoimmunology 2016.